$152 Million is the total value of Iguana Healthcare Management, LLC's 62 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 80.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | SPDR S&P 500 ETF TRput | $13,158,000 | – | 50,000 | +100.0% | 8.66% | – | |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $7,233,000 | -33.4% | 100,000 | -39.4% | 4.76% | -32.7% |
| IMMU | Sell | IMMUNOMEDICS INC | $5,844,000 | -19.6% | 400,000 | -11.1% | 3.84% | -18.8% |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $5,555,000 | +12.9% | 115,000 | -8.0% | 3.65% | +14.1% |
| HUM | Sell | HUMANA INC | $5,377,000 | -3.7% | 20,000 | -11.1% | 3.54% | -2.7% |
| BIIB | Sell | BIOGEN INC | $4,792,000 | -31.6% | 17,500 | -20.5% | 3.15% | -31.0% |
| MRK | MERCK & CO INC | $4,358,000 | -3.2% | 80,000 | 0.0% | 2.87% | -2.2% | |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $3,950,000 | +132.5% | 100,000 | +100.0% | 2.60% | +134.9% |
| SHPG | New | SHIRE PLCsponsored adr | $3,735,000 | – | 25,000 | +100.0% | 2.46% | – |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $3,696,000 | -9.4% | 70,000 | +16.7% | 2.43% | -8.5% |
| New | ESPERION THERAPEUTICS INC NEput | $3,617,000 | – | 50,000 | +100.0% | 2.38% | – | |
| ANAB | Sell | ANAPTYSBIO INC | $3,383,000 | -16.0% | 32,500 | -18.8% | 2.22% | -15.2% |
| CI | Sell | CIGNA CORPORATION | $3,355,000 | -33.9% | 20,000 | -20.0% | 2.21% | -33.2% |
| MYL | Buy | MYLAN N V | $3,294,000 | +94.7% | 80,000 | +100.0% | 2.17% | +96.6% |
| CNC | New | CENTENE CORP DEL | $3,206,000 | – | 30,000 | +100.0% | 2.11% | – |
| BMY | BRISTOL MYERS SQUIBB CO | $3,163,000 | +3.2% | 50,000 | 0.0% | 2.08% | +4.3% | |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $3,065,000 | – | 27,500 | +100.0% | 2.02% | – |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $3,059,000 | +31.9% | 60,000 | +20.0% | 2.01% | +33.2% |
| ABT | Sell | ABBOTT LABS | $2,996,000 | -30.0% | 50,000 | -33.3% | 1.97% | -29.3% |
| LH | New | LABORATORY CORP AMER HLDGS | $2,831,000 | – | 17,500 | +100.0% | 1.86% | – |
| ADMA | ADMA BIOLOGICS INC | $2,760,000 | +43.3% | 600,000 | 0.0% | 1.82% | +44.8% | |
| DXCM | New | DEXCOM INC | $2,596,000 | – | 35,000 | +100.0% | 1.71% | – |
| CBIO | New | CATALYST BIOSCIENCES INC | $2,580,000 | – | 100,000 | +100.0% | 1.70% | – |
| TSRO | Buy | TESARO INC | $2,571,000 | -11.3% | 45,000 | +28.6% | 1.69% | -10.5% |
| ZSAN | New | ZOSANO PHARMA CORP | $2,520,000 | – | 500,000 | +100.0% | 1.66% | – |
| SGMO | Sell | SANGAMO THERAPEUTICS INC | $2,375,000 | -3.5% | 125,000 | -16.7% | 1.56% | -2.5% |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $2,344,000 | – | 125,000 | +100.0% | 1.54% | – |
| GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $2,344,000 | +120.3% | 60,000 | +100.0% | 1.54% | +122.5% |
| MDCO | Buy | MEDICINES CO | $2,306,000 | +40.6% | 70,000 | +16.7% | 1.52% | +42.0% |
| ARMO | New | ARMO BIOSCIENCES INC | $2,245,000 | – | 60,000 | +100.0% | 1.48% | – |
| New | SPDR SERIES TRUSTput | $2,193,000 | – | 25,000 | +100.0% | 1.44% | – | |
| SRRA | Buy | SIERRA ONCOLOGY INC | $2,070,000 | -30.6% | 1,000,000 | +25.0% | 1.36% | -29.9% |
| DPLO | Buy | DIPLOMAT PHARMACY INC | $2,015,000 | +100.7% | 100,000 | +100.0% | 1.33% | +102.8% |
| MYOK | Sell | MYOKARDIA INC | $1,952,000 | -7.3% | 40,000 | -20.0% | 1.28% | -6.3% |
| CTMX | Sell | CYTOMX THERAPEUTICS INC | $1,849,000 | +16.8% | 65,000 | -13.3% | 1.22% | +17.9% |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $1,690,000 | – | 100,000 | +100.0% | 1.11% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $1,689,000 | – | 55,000 | +100.0% | 1.11% | – |
| KPTI | Sell | KARYOPHARM THERAPEUTICS INC | $1,678,000 | -41.7% | 125,000 | -58.3% | 1.10% | -41.2% |
| VKTX | Buy | VIKING THERAPEUTICS INC | $1,639,000 | +79.5% | 375,000 | +66.7% | 1.08% | +81.2% |
| ARWR | New | ARROWHEAD PHARMACEUTICALS IN | $1,442,000 | – | 200,000 | +100.0% | 0.95% | – |
| MRUS | Sell | MERUS N V | $1,390,000 | -28.4% | 75,000 | -25.0% | 0.91% | -27.6% |
| VYGR | Buy | VOYAGER THERAPEUTICS INC | $1,315,000 | +58.4% | 70,000 | +40.0% | 0.86% | +59.9% |
| AKAOQ | Buy | ACHAOGEN INC | $1,295,000 | +60.7% | 100,000 | +33.3% | 0.85% | +62.3% |
| CORI | Buy | CORIUM INTL INC | $1,262,000 | +45.9% | 110,000 | +22.2% | 0.83% | +47.4% |
| INCY | Buy | INCYTE CORP | $1,250,000 | +32.0% | 15,000 | +50.0% | 0.82% | +33.2% |
| CTLT | CATALENT INC | $1,232,000 | 0.0% | 30,000 | 0.0% | 0.81% | +1.0% | |
| CERN | New | CERNER CORP | $1,160,000 | – | 20,000 | +100.0% | 0.76% | – |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $1,160,000 | +65.7% | 200,000 | 0.0% | 0.76% | +67.3% | |
| XNCR | New | XENCOR INC | $1,049,000 | – | 35,000 | +100.0% | 0.69% | – |
| KURA | New | KURA ONCOLOGY INC | $938,000 | – | 50,000 | +100.0% | 0.62% | – |
| SGEN | New | SEATTLE GENETICS INC | $916,000 | – | 17,500 | +100.0% | 0.60% | – |
| SPPI | New | SPECTRUM PHARMACEUTICALS INC | $805,000 | – | 50,000 | +100.0% | 0.53% | – |
| DERM | DERMIRA INC | $799,000 | -71.3% | 100,000 | 0.0% | 0.53% | -71.0% | |
| ASMB | New | ASSEMBLY BIOSCIENCES INC | $737,000 | – | 15,000 | +100.0% | 0.48% | – |
| ADMS | New | ADAMAS PHARMACEUTICALS INC | $717,000 | – | 30,000 | +100.0% | 0.47% | – |
| EXEL | New | EXELIXIS INC | $665,000 | – | 30,000 | +100.0% | 0.44% | – |
| AFMD | New | AFFIMED N V | $555,000 | – | 300,000 | +100.0% | 0.36% | – |
| SCYX | Buy | SCYNEXIS INC | $536,000 | -7.6% | 400,000 | +60.0% | 0.35% | -6.6% |
| OMED | ONCOMED PHARMACEUTICALS INC | $477,000 | -22.4% | 150,000 | 0.0% | 0.31% | -21.7% | |
| KTWO | Sell | K2M GROUP HLDGS INC | $474,000 | -85.0% | 25,000 | -85.7% | 0.31% | -84.8% |
| MRNS | MARINUS PHARMACEUTICALS INC | $382,000 | -53.2% | 100,000 | 0.0% | 0.25% | -52.7% | |
| SLDB | New | SOLID BIOSCIENCES INC | $375,000 | – | 50,000 | +100.0% | 0.25% | – |
| TRXC | Exit | TRANSENTERIX INC | $0 | – | -125,000 | -100.0% | -0.16% | – |
| Exit | NEWLINK GENETICS CORPcall | $0 | – | -50,000 | -100.0% | -0.26% | – | |
| WMGI | Exit | WRIGHT MED GROUP N V | $0 | – | -20,000 | -100.0% | -0.29% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -100,000 | -100.0% | -0.39% | – |
| LHCG | Exit | LHC GROUP INC | $0 | – | -15,000 | -100.0% | -0.60% | – |
| RGNX | Exit | REGENXBIO INC | $0 | – | -30,000 | -100.0% | -0.65% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -50,000 | -100.0% | -0.81% | – |
| ABLX | Exit | ABLYNX NVsponsored adr | $0 | – | -65,000 | -100.0% | -1.05% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -10,000 | -100.0% | -1.06% | – |
| AVXS | Exit | AVEXIS INC | $0 | – | -15,000 | -100.0% | -1.08% | – |
| Exit | CLOVIS ONCOLOGY INCcall | $0 | – | -25,000 | -100.0% | -1.11% | – | |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -17,500 | -100.0% | -1.13% | – |
| AKCA | Exit | AKCEA THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -1.13% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -50,000 | -100.0% | -1.14% | – |
| PFE | Exit | PFIZER INC | $0 | – | -50,000 | -100.0% | -1.18% | – |
| SUPN | Exit | SUPERNUS PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -1.30% | – |
| IONS | Exit | IONIS PHARMACEUTICALS INC | $0 | – | -40,000 | -100.0% | -1.31% | – |
| DHR | Exit | DANAHER CORP DEL | $0 | – | -25,000 | -100.0% | -1.51% | – |
| XENT | Exit | INTERSECT ENT INC | $0 | – | -75,000 | -100.0% | -1.58% | – |
| ZBH | Exit | ZIMMER BIOMET HLDGS INC | $0 | – | -22,500 | -100.0% | -1.77% | – |
| JUNO | Exit | JUNO THERAPEUTICS INC | $0 | – | -60,000 | -100.0% | -1.79% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -50,000 | -100.0% | -3.15% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -85,000 | -100.0% | -3.31% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -75,000 | -100.0% | -5.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 17 | Q1 2018 | 7.5% |
| ULTRAGENYX PHARMACEUTICAL IN | 17 | Q1 2018 | 6.7% |
| MERCK & CO INC NEW | 16 | Q1 2018 | 5.4% |
| CELGENE CORP | 15 | Q4 2017 | 7.9% |
| AERIE PHARMACEUTICALS INC | 15 | Q4 2017 | 3.3% |
| GILEAD SCIENCES INC | 14 | Q1 2017 | 6.7% |
| ESPERION THERAPEUTICS INC NE | 14 | Q1 2018 | 7.8% |
| SUPERNUS PHARMACEUTICALS INC | 14 | Q4 2017 | 2.8% |
| DERMIRA INC | 14 | Q1 2018 | 2.7% |
| AMGEN INC | 13 | Q1 2017 | 6.5% |
View Iguana Healthcare Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-16 |
| 13F-HR | 2017-11-14 |
| 13F-HR | 2017-08-14 |
| 13F-HR | 2017-05-15 |
| 13F-HR | 2017-02-14 |
| 13F-HR/A | 2016-11-17 |
| 13F-HR | 2016-11-14 |
| 13F-HR/A | 2016-11-04 |
View Iguana Healthcare Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.